PI
IONS icon

PEAK6 Investments’s Ionis Pharmaceuticals IONS Stock Holding History

PEAK6 Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$541K Sell
13,500
-1,501
-10% -$69.8K ﹤0.01% 2266
2024
Q2 		$715K Buy
15,001
+4,001
+36% +$164K ﹤0.01% 2052
2024
Q1 		$477K Buy
11,000
+1,999
+22% +$95.3K ﹤0.01% 2480
2023
Q4 		$455K Buy
9,001
+2,499
+38% +$120K ﹤0.01% 2689
2023
Q3 		$295K Buy
+6,502
New +$268K ﹤0.01% 2790
2021
Q1 		– Sell
-22,085
Closed -$1.25M – 5184
2020
Q4 		$1.25M Sell
22,085
-3,806
-15% -$190K ﹤0.01% 2267
2020
Q3 		$1.23M Buy
25,891
+7,751
+43% +$431K ﹤0.01% 2094
2020
Q2 		$1.07M Buy
18,140
+1,493
+9% +$83.1K ﹤0.01% 2026
2020
Q1 		$787K Sell
16,647
-11,687
-41% -$651K ﹤0.01% 1691
2019
Q4 		$1.71M Sell
28,334
-25,793
-48% -$1.54M 0.01% 1190
2019
Q3 		$3.24M Buy
54,127
+33,929
+168% +$2.21M 0.02% 953
2019
Q2 		$1.3M Buy
+20,198
New +$1.43M 0.01% 1607
2019
Q1 		– Sell
-8,415
Closed -$543K – 4197
2018
Q4 		$455K Sell
8,415
-2,693
-24% -$137K ﹤0.01% 2417
2018
Q3 		$573K Buy
+11,108
New +$522K ﹤0.01% 2453

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

PEAK6 Investments's IONS Position: Q3 2024 in Review

PEAK6 Investments reduced its Ionis Pharmaceuticals (IONS) stake by 10% in Q3 2024, selling an estimated $69.8K and leaving 13,500 shares worth $541K. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

PEAK6 Investments first reported a position in IONS in Q3 2018 and has held it in 14 quarters since. The position peaked at $3.24M in Q3 2019. 353 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

  • PEAK6 Investments held 13,500 shares of Ionis Pharmaceuticals worth $541K as of Q3 2024.
  • PEAK6 Investments sold 1,501 Ionis Pharmaceuticals shares in Q3 2024, an estimated $69.8K.
  • Ionis Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2266 holding.
  • PEAK6 Investments first reported a position in Ionis Pharmaceuticals in Q3 2018 and has held it in 14 quarters since.
  • PEAK6 Investments's Ionis Pharmaceuticals position peaked at $3.24M in Q3 2019.
  • 353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.